Get started
Author

Chantal Maria Wiepjes

Observed names: C M Wiepjes, C. M. Wiepjes, C.M. Wiepjes, CM Wiepjes, Chantal M Wiepjes, Chantal M. Wiepjes, Chantal Wiepjes, Wiepjes CM, Wiepjes, C.M., Wiepjes, Chantal, Wiepjes, Chantal M.
Observed institutions: Ghent University Hospital, Amsterdam Public Health, Amsterdam University Medical Centers, Bohn Stafleu van Loghum (Netherlands), Endo-ERN, Amsterdam Gastroenterology Endocrinology Metabolism, Vrije Universiteit Amsterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam
ORCID: 0000-0002-8280-0065
Observed ORCID: 0000-0002-8280-0065
OpenAlex ID: A5016586194
The Amsterdam Cohort of Gender Dysphoria Study (1972–2015): Trends in Prevalence, Treatment, and Regrets
2018 · Chantal M. Wiepjes, Nienke M. Nota, et al. · The Journal of Sexual Medicine · 619
Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands
2019 · Christel J M de Blok, Chantal M Wiepjes, et al. · BMJ · 393
PDF
Occurrence of Acute Cardiovascular Events in Transgender Individuals Receiving Hormone Therapy: Results From a Large Cohort Study
2019 · Nienke M. Nota, Chantal M. Wiepjes, et al. · Circulation · 257
Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study
2017 · M Klaver, C J M de Blok, et al. · European Journal of Endocrinology · 207
PDF
Mortality trends over five decades in adult transgender people receiving hormone treatment: a report from the Amsterdam cohort of gender dysphoria
2021 · Christel JM de Blok, Chantal M Wiepjes, et al. · The Lancet Diabetes & Endocrinology · 177
Bone Safety During the First Ten Years of Gender-Affirming Hormonal Treatment in Transwomen and Transmen
2018 · Chantal M Wiepjes, Renate T de Jongh, et al. · Journal of Bone and Mineral Research · 143
PDF
Cardiovascular disease in transgender people: a systematic review and meta-analysis
2024 · Lieve Mees van Zijverden, Chantal Maria Wiepjes, et al. · European Journal of Endocrinology · 129
PDF
Prospective evaluation of hematocrit in gender‐affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence
2018 · J. Defreyne, B. Vantomme, et al. · Andrology · 119
PDF
Early Hormonal Treatment Affects Body Composition and Body Shape in Young Transgender Adolescents
2018 · Maartje Klaver, Renée de Mutsert, et al. · The Journal of Sexual Medicine · 113
PDF
Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-Term Follow-Up Study on Prevalence, Determinants, and Exposure Years
2021 · Milou Cecilia Madsen, Dennis van Dijk, et al. · The Journal of Clinical Endocrinology & Metabolism · 101
PDF
Trends in suicide death risk in transgender people: results from the Amsterdam Cohort of Gender Dysphoria study (1972–2017)
2020 · C. M. Wiepjes, M. den Heijer, et al. · Acta Psychiatrica Scandinavica · 101
PDF
Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study
2017 · Christel Josefa Maria de Blok, Maartje Klaver, et al. · The Journal of Clinical Endocrinology & Metabolism · 100
PDF
Continuation of gender-affirming hormones in transgender people starting puberty suppression in adolescence: a cohort study in the Netherlands
2022 · Maria Anna Theodora Catharina van der Loos, Sabine Elisabeth Hannema, et al. · The Lancet Child & Adolescent Health · 97
PDF
Fracture Risk in Trans Women and Trans Men Using Long-Term Gender-Affirming Hormonal Treatment: A Nationwide Cohort Study
2019 · Chantal M Wiepjes, Christel JM de Blok, et al. · Journal of Bone and Mineral Research · 92
PDF
Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone Treatment
2020 · Iris de Nie, Christel J M de Blok, et al. · The Journal of Clinical Endocrinology & Metabolism · 91
PDF
The occurrence of benign brain tumours in transgender individuals during cross-sex hormone treatment
2018 · Nienke M Nota, Chantal M Wiepjes, et al. · Brain · 90
PDF
Children and adolescents in the Amsterdam Cohort of Gender Dysphoria: trends in diagnostic- and treatment trajectories during the first 20 years of the Dutch Protocol
2023 · Maria A T C van der Loos, Daniel T Klink, et al. · The Journal of Sexual Medicine · 89
Hormonal Treatment and Cardiovascular Risk Profile in Transgender Adolescents
2020 · Maartje Klaver, Renée de Mutsert, et al. · PEDIATRICS · 89
PDF
Bone Mineral Density Increases in Trans Persons After 1 Year of Hormonal Treatment: A Multicenter Prospective Observational Study
2017 · Chantal M Wiepjes, Mariska C Vlot, et al. · Journal of Bone and Mineral Research · 85
PDF
Change in Visceral Fat and Total Body Fat and the Effect on Cardiometabolic Risk Factors During Transgender Hormone Therapy
2021 · Maartje Klaver, Daan van Velzen, et al. · The Journal of Clinical Endocrinology & Metabolism · 69
PDF
Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study
2021 · Suzanne M E Kuijpers, Chantal M Wiepjes, et al. · The Journal of Clinical Endocrinology & Metabolism · 63
Vaginal bleeding and spotting in transgender men after initiation of testosterone therapy: A prospective cohort study (ENIGI)
2020 · Justine Defreyne, Yuran Vanwonterghem, et al. · International Journal of Transgender Health · 63
Change in grip strength in trans people and its association with lean body mass and bone density
2019 · Miranda Scharff, Chantal Maria Wiepjes, et al. · Endocrine Connections · 62
PDF
The effect of transdermal gender-affirming hormone therapy on markers of inflammation and hemostasis
2022 · Moya H. Schutte, Robert Kleemann, et al. · PLoS ONE · 61
PDF
Transgender Girls Grow Tall: Adult Height Is Unaffected by GnRH Analogue and Estradiol Treatment
2022 · Lidewij Sophia Boogers, Chantal Maria Wiepjes, et al. · The Journal of Clinical Endocrinology & Metabolism · 55
PDF
Works count: 125
Citation count: 4,565
H-index: 35
I10-index: 61
Year
Topic
Type